© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
February 27, 2021
A discussion on continued research into the first regulated treatment for pediatric peanut allergy.
January 28, 2021
Pending FDA decision, the Viaskin Peanut patch would be considered for lengthier benefit studies.
January 25, 2021
The epicutaneous immunotherapy for peanut allergy is continuing discussions with the FDA. What is its potential in allergic care?
January 22, 2021
In the initial report, investigators find just 2.5 cases of anaphylaxis per million doses of the Moderna COVID-19 vaccine.
January 21, 2021
An individualized model that provides vaccine-hesitant patients resources without compromising autonomy could aid efforts to limit the pandemic with new vaccines.
January 13, 2021
A conversation on how associations between the chronic conditions have become better understood in 10 years.
January 11, 2021
A discussion around obesity's effect on asthma, and the newest recommendations for managed care.
January 07, 2021
In nearly 1.9 million doses of the COVID-19 vaccine there has been only 21 total cases of anaphylaxis.
December 25, 2020
New research adds to the case that some children are genetically more susceptible to allergic disease.
December 15, 2020
Preschool children with asthma, food allergies, and pollen/fur or dust mite allergies are at increased risk of having concurrent mental health problems.